Patent · US Active

Anti-CD3 epsilon antibodies and methods of use thereof

US11203646B2 · kind B2 · utility

1Cited by

19References

24Claims

0Family size

Assignee

Novimmune SA · CH

Inventors

Nicolas Fischer · Geneva, CH
Giovanni Magistrelli · Gex, FR
Franck Gueneau · Saint-Julien-en-Genevois, FR
Ulla Ravn · Geneva, CH

Key dates

Filing date	Mar 14, 2019
Grant date	Dec 21, 2021
Priority date	—
Expiry date	Jun 8, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/565
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The disclosure relates to monoclonal antibodies and antigen binding fragments, variants, multimeric versions, or bispecifics thereof that specifically bind CD3 epsilon (CD3ε), as well as methods of making and using these anti-CD3ε antibodies and antigen binding fragments thereof in a variety of therapeutic, diagnostic and prophylactic indications.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.